Patents Assigned to Phigenix, Inc
  • Targeting PAX2 for the treatment of breast cancer
    Patent number: 8080534
    Abstract: The present application provides methods of prevention and/or treatment of breast cancer in a subject by inhibiting expression of PAX2. In the certain embodiments, the method of inhibiting expression of PAX2 is to administrate the subject a nucleic acid encoding an siRNA for PAX2. A method of treating cancer in a subject by administering DEFB1 or by increasing expression of DEFB1 is also provided.
    Type: Grant
    Filed: February 18, 2010
    Date of Patent: December 20, 2011
    Assignee: Phigenix, Inc
    Inventor: Carlton D. Donald
  • COMPOSITIONS AND METHODS FOR DIAGNOSING, TREATING, AND PREVENTING PROSTATE CONDITIONS
    Publication number: 20100029560
    Abstract: Disclosed are compositions and methods for diagnosing, preventing, and treating prostate cancer and prostate intraepithelial neoplasia (PIN).
    Type: Application
    Filed: January 16, 2008
    Publication date: February 4, 2010
    Applicant: PHIGENIX, INC
    Inventor: Carlton D. Donald